Revenue
$5.54B
Gross Margin
+61.7%
Operating Margin
+34.3%
Net Margin
+27.4%
Income statement waterfall for ResMed (RMD) — TTM through Q1 2026
Net income: $1.52B
Margin breakdown for ResMed (RMD) — TTM through Q1 2026
| Line item | Amount | Running total |
|---|---|---|
| Revenue | $5.54B | $5.54B |
| Cost of Revenue | -$2.12B | $3.42B |
| Gross Profit | $3.42B | $3.42B |
| Operating Expenses | -$1.52B | $1.9B |
| Operating Income | $1.9B | $1.9B |
| Other Income / Expense | $4.82M | $1.9B |
| Pre-tax Income | $1.9B | $1.9B |
| Income Tax | -$384M | $1.52B |
| Net Income | $1.52B | $1.52B |
- Revenue$5.54B
- Cost of Revenue-$2.12B
- Gross Profit$3.42B
- Operating Expenses-$1.52B
- Operating Income$1.9B
- Other Income / Expense$4.82M
- Pre-tax Income$1.9B
- Income Tax-$384M
- Net Income$1.52B
Want to see what changed vs last year?Profit Bridge
Frequently asked questions
Data & methodology
ResMed (RMD) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Cash Flow
Forecast & Valuation
Operations
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement
Capital Return
- Buybacks1.82% TTM
- Dividend Profile1.24% yield
- Dividend Calculator
- Dividend Forecast
- Dividend Capture
- Stock Split History4 splits
How this company returns cash to shareholders — buybacks, dividends, and stock splits.